• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

作者更正:SWI/SNF复合物中的突变诱导肺癌对氧化磷酸化产生可靶向的依赖性。

Author Correction: Mutations in the SWI/SNF complex induce a targetable dependence on oxidative phosphorylation in lung cancer.

作者信息

Deribe Yonathan Lissanu, Sun Yuting, Terranova Christopher, Khan Fatima, Martinez-Ledesma Juan, Gay Jason, Gao Guang, Mullinax Robert A, Khor Tin, Feng Ningping, Lin Yu-Hsi, Wu Chia-Chin, Reyes Claudia, Peng Qian, Robinson Frederick, Inoue Akira, Kochat Veena, Liu Chang-Gong, Asara John M, Moran Cesar, Muller Florian, Wang Jing, Fang Bingliang, Papadimitrakopoulou Vali, Wistuba Ignacio I, Rai Kunal, Marszalek Joseph, Futreal P Andrew

机构信息

Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

出版信息

Nat Med. 2018 Oct;24(10):1627. doi: 10.1038/s41591-018-0173-9.

DOI:10.1038/s41591-018-0173-9
PMID:30104769
Abstract

In the version of this article originally published, information regarding several funding sources was omitted from the Acknowledgements section. The following sentences should have been included: "This work was supported by the generous philanthropic contributions to The University of Texas MD Anderson Lung Cancer Moon Shots Program, the UT Lung SPORE 5 P50 CA07090, and the MD Anderson Cancer Center Support Grant P30CA01667. V.P is supported by R01CA155196-01A1 from the National Cancer Institute." Also, reference 18 was incorrect. The original reference was: Kim, E. S. et al. The BATTLE trial: personalizing therapy for lung cancer. Cancer Discov. 1, 44-53 (2011). It should have been: Papadimitrakopoulou, V. et al. The BATTLE-2 study: a biomarker-integrated targeted therapy study in previously treated patients with advanced non-small-cell lung cancer. J Clin. Oncol. 34, 3638-3647 (2016). The errors have been corrected in the HTML and PDF versions of this article.

摘要

在本文最初发表的版本中,致谢部分遗漏了关于几个资金来源的信息。应包含以下句子:“这项工作得到了对德克萨斯大学MD安德森肺癌登月计划的慷慨慈善捐款、UT肺癌特殊项目研究经费5 P50 CA07090以及MD安德森癌症中心支持拨款P30CA01667的支持。V.P.得到了美国国立癌症研究所R01CA155196 - 01A1的支持。”此外,参考文献18有误。原参考文献为:Kim, E. S.等人。BATTLE试验:肺癌的个体化治疗。《癌症发现》1, 44 - 53(2011)。应为:Papadimitrakopoulou, V.等人。BATTLE - 2研究:一项针对先前治疗过的晚期非小细胞肺癌患者的生物标志物整合靶向治疗研究。《临床肿瘤学杂志》34, 3638 - 3647(2016)。本文的HTML和PDF版本已对这些错误进行了更正。

相似文献

1
Author Correction: Mutations in the SWI/SNF complex induce a targetable dependence on oxidative phosphorylation in lung cancer.作者更正:SWI/SNF复合物中的突变诱导肺癌对氧化磷酸化产生可靶向的依赖性。
Nat Med. 2018 Oct;24(10):1627. doi: 10.1038/s41591-018-0173-9.
2
AURA3 trial: does Tagrisso (osimertinib) have the potential to become the new standard of care for second-line treatment of patients with T790M mutation-positive locally advanced or metastatic NSCLC.AURA3试验:泰瑞沙(奥希替尼)是否有潜力成为T790M突变阳性的局部晚期或转移性非小细胞肺癌患者二线治疗的新标准。
Lung Cancer Manag. 2016 Dec;5(4):159-162. doi: 10.2217/lmt-2017-0001. Epub 2017 Mar 6.
3
Author Correction: Comparing phenotypic variation between inbred and outbred mice.作者更正:比较近交系和远交系小鼠之间的表型变异。
Nat Methods. 2019 Feb;16(2):206. doi: 10.1038/s41592-018-0298-2.
4
Author Correction: Metformin reverses established lung fibrosis in a bleomycin model.作者更正:二甲双胍可逆转博来霉素模型中已形成的肺纤维化。
Nat Med. 2018 Oct;24(10):1627. doi: 10.1038/s41591-018-0170-z.
5
Author Correction: Meridional heat transport variability induced by mesoscale processes in the subpolar North Atlantic.作者更正:北极亚极地中尺度过程引起的经向热输送变化
Nat Commun. 2018 Jun 14;9(1):2398. doi: 10.1038/s41467-018-04809-1.
6
Publisher Correction: The impact of endothermy on the climatic niche evolution and the distribution of vertebrate diversity.出版商更正:恒温对气候生态位演化及脊椎动物多样性分布的影响。
Nat Ecol Evol. 2018 Mar;2(3):578. doi: 10.1038/s41559-018-0492-8.
7
Author Correction: Gene correction for SCID-X1 in long-term hematopoietic stem cells.作者更正:长期造血干细胞中X连锁重症联合免疫缺陷病(SCID-X1)的基因校正
Nat Commun. 2019 Apr 26;10(1):2021. doi: 10.1038/s41467-019-10080-9.
8
Author Correction: A chip-integrated coherent photonic-phononic memory.作者更正:芯片集成相干光子 - 声子存储器。
Nat Commun. 2018 Jan 4;9(1):109. doi: 10.1038/s41467-017-02506-z.
9
Author Correction: Signatures of the topological s superconducting order parameter in the type-II Weyl semimetal T -MoTe.作者更正:II型外尔半金属T₂-MoTe₂中拓扑超导序参量的特征
Nat Commun. 2018 Jan 10;9(1):201. doi: 10.1038/s41467-017-02460-w.
10
Author Correction: Ultra-thin high-efficiency mid-infraredtransmissive Huygens meta-optics.作者更正:超薄高效中红外透射惠更斯超表面光学器件
Nat Commun. 2018 Jun 14;9(1):2399. doi: 10.1038/s41467-018-04890-6.

引用本文的文献

1
Lefamulin Overcomes Acquired Drug Resistance via Regulating Mitochondrial Homeostasis by Targeting ILF3 in Hepatocellular Carcinoma.左氟沙星通过靶向 ILF3 调控肝癌线粒体稳态克服获得性耐药。
Adv Sci (Weinh). 2024 Aug;11(30):e2401789. doi: 10.1002/advs.202401789. Epub 2024 Jun 14.
2
Treatment of Thoracic SMARCA4-Deficient Undifferentiated Tumors: Where We Are and Where We Will Go.治疗胸内 SMARCA4 缺陷型未分化肿瘤:现状与展望。
Int J Mol Sci. 2024 Mar 13;25(6):3237. doi: 10.3390/ijms25063237.
3
Molecular markers of metastatic disease in KRAS-mutant lung adenocarcinoma.
KRAS 突变型肺腺癌转移病的分子标志物。
Ann Oncol. 2023 Jul;34(7):589-604. doi: 10.1016/j.annonc.2023.04.514. Epub 2023 Apr 29.
4
Hyperbaric oxygen enhanced the chemotherapy of mitochondrial targeting molecule IR-780 in bladder cancer.高压氧增强了线粒体靶向分子 IR-780 对膀胱癌的化疗效果。
J Cancer Res Clin Oncol. 2023 Feb;149(2):683-699. doi: 10.1007/s00432-022-04385-4. Epub 2022 Nov 27.
5
Arid1a regulates bladder urothelium formation and maintenance.Arid1a 调节膀胱尿路上皮的形成和维持。
Dev Biol. 2022 May;485:61-69. doi: 10.1016/j.ydbio.2022.02.008. Epub 2022 Mar 10.
6
BRD4 inhibition induces synthetic lethality in ARID2-deficient hepatocellular carcinoma by increasing DNA damage.BRD4 抑制通过增加 DNA 损伤诱导 ARID2 缺陷型肝细胞癌的合成致死性。
Oncogene. 2022 Mar;41(10):1397-1409. doi: 10.1038/s41388-022-02176-2. Epub 2022 Jan 11.
7
Exploiting vulnerabilities of SWI/SNF chromatin remodelling complexes for cancer therapy.利用 SWI/SNF 染色质重塑复合物的漏洞进行癌症治疗。
Oncogene. 2021 May;40(21):3637-3654. doi: 10.1038/s41388-021-01781-x. Epub 2021 May 3.
8
The role of the SWI/SNF chromatin remodeling complex in pancreatic ductal adenocarcinoma.SWI/SNF 染色质重塑复合物在胰腺导管腺癌中的作用。
Cancer Sci. 2021 Feb;112(2):490-497. doi: 10.1111/cas.14768. Epub 2020 Dec 28.
9
Blocking PPARγ interaction facilitates Nur77 interdiction of fatty acid uptake and suppresses breast cancer progression.阻断 PPARγ 相互作用促进 Nur77 抑制脂肪酸摄取并抑制乳腺癌进展。
Proc Natl Acad Sci U S A. 2020 Nov 3;117(44):27412-27422. doi: 10.1073/pnas.2002997117. Epub 2020 Oct 21.
10
Synthetic lethal therapy based on targeting the vulnerability of SWI/SNF chromatin remodeling complex-deficient cancers.基于靶向 SWI/SNF 染色质重塑复合物缺陷型癌症脆弱性的合成致死疗法。
Cancer Sci. 2020 Mar;111(3):774-782. doi: 10.1111/cas.14311. Epub 2020 Feb 22.